Page last updated: 2024-09-04

sk&f 83959 and Pituitary Neoplasms

sk&f 83959 has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, L; Guo, YH; Le, WD; Leng, ZG; Lin, SJ; Lou, MQ; Shang, HB; Tang, H; Wu, ZB; Wu, ZR; Xue, YJ; Zhang, X; Zhao, W; Zhao, WG	1

Other Studies

1 other study(ies) available for sk&f 83959 and Pituitary Neoplasms

Article	Year
Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death. Autophagy, 2017, Aug-03, Volume: 13, Issue:8 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autophagosomes; Autophagy; Cabergoline; Cell Line, Tumor; Cell Proliferation; Ergolines; Humans; Mice, Nude; Pituitary Neoplasms; Rats; Reactive Oxygen Species; Receptors, Dopamine D5; Superoxide Dismutase; TOR Serine-Threonine Kinases	2017

Article

Year

Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death.

Autophagy, 2017, Aug-03, Volume: 13, Issue:8

Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autophagosomes; Autophagy; Cabergoline; Cell Line, Tumor; Cell Proliferation; Ergolines; Humans; Mice, Nude; Pituitary Neoplasms; Rats; Reactive Oxygen Species; Receptors, Dopamine D5; Superoxide Dismutase; TOR Serine-Threonine Kinases

2017